Head-to-head dispatch
Pallas Health vs Vaylen
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Pallas Health names all six of the pharmacies that dispense for it and two prescribing clinicians whose NPIs verify in the federal registry — then sells every GLP-1 on a single twelve-week prepay, so the advertised “/mo average” is one $597 or $897 charge divided by three.
Marked down on: There is no month-to-month rung for either compounded molecule — the funnel renders no cadence selector — so the advertised “$199/mo average” is a single $597 charge every twelve weeks divided by three
Desk Score
The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.
Marked down on: Newer operator with a shorter track record
Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 87/100 (B+) for Pallas Health. Pallas Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Pallas Health
87/100
B+
Vaylen
91/100
A−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Pallas Health | Vaylen |
|---|---|---|
| Semaglutide | $199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) | $179/mo |
| Tirzepatide | $299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) | $239/mo |
| Coverage | All 50 states + DC (async in 43; 7 states plus DC require one video visit) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Yes |
| Best for | Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one. | People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach. |
| Desk Score | 87/100B+ | 91/100A− |
The verdict
Desk pick — VaylenVaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 87/100 (B+) for Pallas Health. Pallas Health still holds its ground where its strengths line up with yours.
Choose Pallas Health if…
Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) sema · $299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) tirz · All 50 states + DC (async in 43; 7 states plus DC require one video visit)
Choose Vaylen if…
People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
$179/mo sema · $239/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Pallas Health · Vaylen.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Pallas Health vs CoreAge Rx
- Vaylen vs Strut Health
- Pallas Health vs Ondra Health
- Vaylen vs Invigor Medical
- Pallas Health vs Vytora Health
- Vaylen vs Sesame Care
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.